Restoration of the endothelial function in the aortic rings of apolipoprotein E deficient mice by pharmacological inhibition of the nuclear enzyme poly(ADP-ribose) polymerase

Life Sciences

Volumn 75, Issue 10, 2004, Pages 1255-1261

  Benkö, Rita ^a,b   Pacher, Pál ^a,b   Vaslin, Anne ^a   Kollai, Márk ^b   Szabó, Csaba ^a,b  

^a INOTEK CORPORATION   (United States)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Atherosclerosis; DNA; Endothelium; Oxidative stress

Indexed keywords

ACETYLCHOLINE; APOLIPOPROTEIN E; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; POLY(ADENOSINE DIPHOSPHATE RIBOSE);

ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; INCUBATION TIME; LIPID DIET; LIPOPROTEIN DEFICIENCY; MOUSE; NONHUMAN; VASCULAR RING; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; APOLIPOPROTEINS E; DIETARY FATS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; MICE; MICE, KNOCKOUT; ORGAN CULTURE TECHNIQUES; POLY(ADP-RIBOSE) POLYMERASES; RECOVERY OF FUNCTION; VASODILATION;

EID: 3042643028     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.04.007     Document Type: Article

References (31)

1. Chen J., Kuhlencordt P., Urano F., Ichinose H., Astern J., Huang P.L. Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE/inducible NO synthase double-knockout mice. Arteriosclerosis Thrombosis Vascular Biology. 23(1):2003;97-103
2. Cuzzocrea S., Zingarelli B., Costantino G., Szabo A., Salzman A.L., Caputi A.P., Szabo C. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. British Journal of Pharmacology. 121(6):1997;1065-1074
3. Daugherty A. Mouse models of atherosclerosis. American Journal of Medical Science. 323(1):2002;3-10
4. d'Uscio L.V., Smith L.A., Katusic Z.S. Hypercholesterolemia impairs endothelium-dependent relaxations in common carotid arteries of apolipoprotein e-deficient mice. Stroke. 32(11):2001;2658-2664
5. Garcia Soriano F., Virag L., Jagtap P., Szabo E., Mabley J.G., Liaudet L., Marton A., Hoyt D.G., Murthy K.G., Salzman A.L., Southan G.J., Szabo C. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nature Medicine. 7(1):2001;108-113
6. Gervais M., Pons S., Nicoletti A., Cosson C., Giudicelli J.F., Richer C. Fluvastatin prevents renal dysfunction and vascular NO deficit in apolipoprotein E-deficient mice. Arteriosclerosis Thrombosis Vascular Biology. 23(2):2003;183-189
7. Godecke A., Ziegler M., Ding Z., Schrader J. Endothelial dysfunction of coronary resistance vessels in apoE-/- mice involves NO but not prostacyclin-dependent mechanisms. Cardiovascular Research. 53(1):2002;253-262
8. Hassa P.O., Hottiger M.O. The functional role of poly(ADP-ribose) polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders. Cellular Molecular Life Sciences. 59(9):2002;1534-1553
9. Jiang F., Guo Y., Salvemini D., Dusting G.J. Superoxide dismutase mimetic M40403 improves endothelial function in apolipoprotein(E)-deficient mice. British Journal of Pharmacology. 139(6):2003;1127-1134
10. Jiang F., Jones G.T., Husband A.J., Dusting G.J. Cardiovascular protective effects of synthetic isoflavone derivatives in apolipoprotein e-deficient mice. Journal of Vascular Research. 40(3):2003;276-284
11. Khan T.A., Ruel M., Bianchi C., Voisine P., Komjati K., Szabo C., Sellke F.W. Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass. Journal of American College of Surgeons. 197(2):2003;270-277
12. Knowles J.W., Reddick R.L., Jennette J.C., Shesely E.G., Smithies O., Maeda N. Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment. Journal of Clinical Investigation. 105(4):2000;451-458
13. Laursen J.B., Somers M., Kurz S., McCann L., Warnholtz A., Freeman B.A., Tarpey M., Fukai T., Harrison D.G. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation. 103(9):2001;1282-1288
14. Martinet W., Knaapen M.W., De Meyer G.R., Herman A.G., Kockx M.M. Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering. Circulation Research. 88(7):2001;733-739
15. Martinet W., Knaapen M.W., De Meyer G.R., Herman A.G., Kockx M.M. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation. 106(8):2002;927-932
16. Matsumoto T., D'uscio L.V., Eguchi D., Akiyama M., Smith L.A., Katusic Z.S. Protective effect of chronic vitamin C treatment on endothelial function of apolipoprotein E-deficient mouse carotid artery. Journal of Pharmacology and Experimental Therapeutics. 306(1):2003;103-108
17. Murthy K.G., Xiao C.Y., Mabley J.G., Chen M., Szabo C. Activation of poly(ADP-ribose) polymerase in circulating leukocytes during myocardial infarction. Shock. 21(3):2003;230-234
18. Pacher P., Liaudet L., Soriano F.G., Mabley J.G., Szabo E., Szabo C. The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes. 51(2):2002;514-521
19. Pacher P., Liaudet L., Mabley J., Komjati K., Szabo C. Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure. Journal of the American College of Cardiology. 40(5):2002;1006-1016
20. Pacher P., Mabley J.G., Soriano F.G., Liaudet L., Komjati K., Szabo C. Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation. British Journal of Pharmacology. 135(6):2002;1347-1350
21. Shimoda K., Murakami K., Enkhbaatar P., Traber L.D., Cox R.A., Hawkins H.K., Schmalstieg F.C., Komjati K., Mabley J.G., Szabo C., Salzman A.L., Traber D.L. Effect of poly(ADP ribose) synthetase inhibition on burn and smoke inhalation injury in sheep. American Journal of Physiology Lung Cellular and Molecular Physiology. 285(1):2003;L240-L249
22. Soriano F.G., Pacher P., Mabley J., Liaudet L., Szabo C. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase. Circulation Research. 89(8):2001;684-691
23. Szabo C., Cuzzocrea S., Zingarelli B., O'Connor M., Salzman A.L. Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. Journal of Clinical Investigation. 100(3):1997;723-735
24. Szabo C., Dawson V.L. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends in Pharmacological Sciences. 19(7):1998;287-298
25. Szabo G., Buhmann V., Andrasi T., Stumpf N., Bahrle S., Kekesi V., Hagl S., Szabo C., Juhasz-Nagy A. Poly-ADP-ribose polymerase inhibition protects against myocardial and endothelial reperfusion injury after hypothermic cardiac arrest. Journal of Thoracic and Cardiovascular Surgery. 126(3):2003;651-658
26. Szabo C., Pacher P., Komjati K., Mabley J.G., Benko R., Kollai M. Poly(ADP-ribose) polymerase (PARP) activation is an early event in angiotensin-induced cardiovascular disorders. FASEB Journal. 17(1):2003;A803
27. Tham D.M., Martin-McNulty B., Wang Y.X., Da Cunha V., Wilson D.W., Athanassious C.N., Powers A.F., Sullivan M.E., Rutledge J.C. Angiotensin II injures the arterial wall causing increased aortic stiffening in apolipoprotein E-deficient mice. American Journal of Physiology Regulatory and Integrative Comparative Physiology. 283(6):2002;R1442-R1449
28. Virag L., Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacological Reviews. 54(3):2002;375-429
29. Wattanapitayakul S.K., Weinstein D.M., Holycross B.J., Bauer J.A. Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders. FASEB Journal. 14(2):2000;271-278
30. Wolf G. Free radical production and angiotensin. Current Hypertension Report. 2(2):2000;167-173
31. Zhang C., Yang J., Jennings L.K. Attenuation of neointima formation through the inhibition of DNA repair enzyme PARP-1 in balloon-injured rat carotid artery. American Journal of Physiology Heart and Circulatory Physiology. 2004;. (Mar 25 [Epub ahead of print])